Otsuka Works with Verily to Launch Longitudinal Mental Health Registry to Advance Novel Research in Psychiatry
Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka), a global pharmaceutical company, announces the launch of My Mental Health Journey , a longitudinal registry study that aims to advance research in depression and mental health.
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka), a global pharmaceutical company, announces the launch of My Mental Health Journey , a longitudinal registry study that aims to advance research in depression and mental health.
- Verily Life Sciences LLC (Verily), a precision health technology company, will recruit participants and run the study.
- View the full release here: https://www.businesswire.com/news/home/20240404726198/en/
The My Mental Health Journey registry will enroll U.S.-based adults experiencing symptoms of depression to help Otsuka better understand mental health conditions, such as major depressive disorder, across time and in the real-world setting. - Participants in the My Mental Health Journey may receive compensation for study activities, educational resources, updates on future clinical studies, and other opportunities to help advance depression research.